ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $124K of Arcutis Biotherapeutics, Inc.
Sold$123,835
$26.18Price
4,730Shares
−11%Stake
What ARQT did after the filing
- The stock from Thu, Aug 20 open, $26.50
- −5.1%
- S&P 500, same days
- +0.5%
Measured over 30 trading days, to the Oct 2 close.
Traded Mon, Aug 17. Filed Wed, Aug 19, 4:57 PM ET, after the close. Returns use the Aug 20 open and the Oct 2 close. Not investment advice.